Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
test
test
test
"When the going gets weird
...the weird turn pro"
Hunter Thompson
CBAY bottom fishing buy opp. 0.08 last /e
CBAY - bottom fishing buy opp. 0.08 last /e
CBAY running 0.091 last /e
out ADSX 2.34 /e
My 1.618 cents worth on methods...
I know E-wave best. I have built back-tested spreadsheets that have occasionally been accurate to the point of being spooky. (for ex: back on 10/5 I mentioned that ewave suggested if there was a COMP upside break of 2314ish next stop/turn was an extended 5th top to 2376...actual top last week: 2379...and this was basically baked in the cake and in the math from August)
BUT, saying that, the Hurst analysis as displayed on this site is just nothing short of phe-nominal-ly accurate and consistant. No matter WHAT my numbers said to me, I would'nt fade the hurst calls here. Maybe just tighten stops.
I use my ewave to spot points of interest based on these fibonacci paterns in nature and to suggest expectant behavior. The more standard the behavior of past movement in ewave analysis, the more credence I put in my next batch sequence of #'s. There is an explanation or at least a name for every developed pattern which in turn suggests what's coming in the Future.
*First do no harm*...
I try to use as much compatable input as reasonable w/out ending up in analysis paralysis. Such as varifiable trend line (VTL) and channel breaches which are never to be ignored.
I plan to start learning the Hurst methods as best I can and soon...if that is a message. And, I see that path as a daunting and exciting challenge in my old age.
A
You're right, as stated in the PR /e
ADSX tags 200dma ahead of earnings...
FDA approved chip
The chip is ALREADY FDA approved...
VeriChip Corporation Adds 73 Physicians to VeriMed Physician Network at the PriMed East Medical Conference in Boston
By BusinessWire
Last Update: 11/1/2006 10:00:21 AM Data provided by
DELRAY BEACH, Fla., Nov 01, 2006 (BUSINESS WIRE) -- VeriChip Corporation, a subsidiary of Applied Digital Solutions (ADSX), announced today the VeriMed Physician Network grew by 73 physicians as a result of exhibiting at the PriMed East Medical Conference held from October 27-29 in Boston. The PriMed Conference marks the third large medical conference for primary care physicians in the past month in which VeriMed, the first and only FDA-approval implantable RFID microchip system for patient identification and access to healthcare information, has been exhibited. Including the results of the PriMed East Medical Conference, the American Academy of Family Physicians Medical Conference, and the American Osteopathy Association Medical Conference, the number of physicians in the VeriMed Physician Network has grown to more than 1,100.
"We are pleased with the physician interest shown in VeriMed from the PriMed Conference and other medical conferences," said Kevin McLaughlin, CEO of VeriChip Corporation. "The footprint of the VeriMed Physician Network is nationwide, which shows the widespread acceptance for VeriMed. We will continue to work with physicians as we endeavor to establish VeriMed as a leading patient identification, record storage and retrieval system."
Recently, the Company announced that 67 healthcare facilities agreed to participate in the VeriMed Patient Identification System Network at the American College of Emergency Physicians (ACEP) Conference in New Orleans held from October 15-18. These healthcare facilities agreed to use the VeriMed reader as standard protocol to scan patients that arrive in emergency rooms unconscious, delirious or confused. That brings the total number of hospitals and healthcare facilities that have agreed to adopt the VeriMed System to 258. These hospitals and healthcare facilities are located in 35 states.
About PriMed
PriMed conferences are leading medical conferences for primary care physicians conducted annually in seven major U.S. regions. The purpose of these conferences is to educate physicians about critical healthcare issues as well as new medicines and medical technologies.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.
About Applied Digital - "The Power of Identification Technology"
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (DOC).
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
SOURCE: VeriChip Corporation
WAVX nice move...
Congrats all ANSW'rs /e
ADSX fwiw
ADSX bounced at $2.04 which is the precise .618 retracement of the insane move to $2.82 yesterday. Now in a W5 and cautiously moving up. 5th waves are at best a bit dangerous to trade as they can fail quickly. Yesterday's move of an extended W3 with so much volume sucked a lot of juice out of the stock, so a full W5 (or extended W5) is tough to predict.
This stock has long term legs,imo but short term price will still be spec driven until there is more revenue.
GLGT
A
ADSX down thru 2nd retracement...
away from home compter so can't give est. of .5 and.618 as next stops on the way down and potential bounces.
Would like to see clear break of DTL from $2.82 now before going long again.
Earnings early in Nov. as well (3rd?)
gl
A
ADSX bounce correction estimates...
based on runnup to $2.82 (= a W3 of 3.5 * W1 and Very rare...1.618 W1 is std.) today...
W4 corrections: down to...$2.52 (.236)W3 or $2.34 (.382 W3)
First watch level occuring now...12:30 Eastern
ADSX $2.70...insane /e
This is whats going on...
Digital Angel Corporation Awarded Patent for Breakthrough Glucose-Sensing RFID Microchip
By BusinessWire
Last Update: 10/25/2006 10:00:28 AM Data provided by
SOUTH ST. PAUL, Minn., Oct 25, 2006 (BUSINESS WIRE) -- The U.S. Patent and Trademark Office has granted Digital Angel Corporation (DOC) a patent for its syringe-implantable glucose-sensing RFID microchip, Digital Angel announced today. The RFID microchip measures the glucose concentration levels of diabetic patients and will be marketed and distributed by Digital Angel's sister company, VeriChip, as an extension to the company's products benefiting people.
"A glucose-sensing microchip could profoundly impact the 230 million people worldwide living with diabetes," said Digital Angel CEO and President, Kevin McGrath. "Patent approval for this RFID microchip is a major step in bringing this life-altering technology to market. It also underscores Digital Angel's commitment to innovation, product development and rapid growth."
Checking blood glucose levels regularly is critical to properly managing diabetes. The conventional method - a finger prick - is invasive, painful and often inaccurate. The implantable bio-sensor chip has a passive transponder, glucose sensor and integrated circuitry that allow anyone implanted with the microchip to painlessly scan it to determine their level of glucose concentration. The RFID microchip quickly and accurately transmits the glucose data back to a wireless scanner that displays the glucose level. The RFID microchip is powered by the scanner signal, avoiding the need for a battery in the microchip.
"This is a landmark development in the world of diabetes management," said Dr. Joseph Feldman, Chairman of the Emergency/Trauma Department of Hackensack University Medical Center. "The current process for monitoring blood sugar levels is painful, cumbersome and discouraging, and especially burdensome for the young and the elderly. By having this technology, the process becomes effortless. This glucose-sensing RFID microchip is the next great step in implantable microchip technology."
Digital Angel, a leading producer of electronic tags for livestock, pets, fish and humans, foresees expansion beyond the human market for the glucose-sensing RFID microchip. According to the company, diabetes is a major disease issue in animal livestock today. As a result, the glucose-sensing RFID microchip could have an equally significant impact in monitoring the glucose levels in livestock animals.
"We recognize that extensive work is required to commercialize this product, including the time and investment required for development, clinical trials and FDA approval," said McGrath. "Still, we view this as an incredibly important advancement in the world of diabetes management."
Digital Angel is seeking international patent protection covering the same glucose-sensor RFID technology. The company, in conjunction with VeriChip Corporation, its exclusive licensee in the area of human implantable identification products, is in the process of naming this product.
The patent, No. 7,125,382 was granted on October 24, 2006 and is titled "Embedded Bio-Sensor System."
About Digital Angel Corporation
Digital Angel Corporation develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (ADSX). For more information about Digital Angel, please visit www.DigitalAngelCorp.com.
The statements in this press release that are not strictly historical, are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to be covered by the safe harbors created by these sections. The forward-looking statements are subject to risks and uncertainties and the actual results that the Company achieves may differ materially from these forward-looking statements due to such risks and uncertainties, including, but not limited to, that Applied Digital Inc. owns 55.4% of the Company's common stock, that new accounting pronouncements regarding expensing of share based compensation may impact the Company's future results of operations, the Company may continue to incur net losses, infringement by third parties on the Company's intellectual property or development of substantially equivalent proprietary technology by the Company's competitors could negatively impact the Company's business, domestic and foreign government regulation and other factors could impair the Company's ability to develop and sell its products in certain markets, the Company relies on sales to government contractors for its animal identification and search and rescue beacon products, and any decline in the demand by these customers for such products could negatively affect the Company's business, the Company depends on a single production arrangement for its patented syringe-injectable microchips, and the loss of or any significant reduction in the production could have an adverse effect on the Company's business, technological change could cause the Company's products to become obsolete, the loss of one of the Company's principal customers could negatively impact the Company's net revenue, the Company's earnings will decline if the Company writes off goodwill and other intangible assets, options and warrants outstanding and available for issuance may adversely affect the market price of the Company's common stock, currency exchange rate fluctuations could have an adverse effect on the Company's sales and financial results, the Company depends on a small team of senior management. A detailed statement of risks and uncertainties is contained in the Company's reports to the Securities and Exchange Commission, including in particular the Company's Form 10-K for the fiscal year ended December 31, 2005. Investors and stockholders are urged to read this document carefully. The Company can offer no assurances that any projections, assumptions or forecasts made or discussed in this release will be met, and investors should understand the risks of investing solely due to such projections. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
SOURCE: Digital Angel Corporation
ADSX $2.26 /e
ADSX breakout $1.94 last.../e
ADSX patent awarded...
Digital Angel Corporation Awarded Patent for Breakthrough Glucose-Sensing RFID Microchip
By BusinessWire
Last Update: 10/25/2006 8:00:21 AM Data provided by
SOUTH ST. PAUL, Minn., Oct 25, 2006 (BUSINESS WIRE) -- The U.S. Patent and Trademark Office has granted Digital Angel Corporation (DOC) a patent for its syringe-implantable glucose-sensing RFID microchip, Digital Angel announced today. The RFID microchip measures the glucose concentration levels of diabetic patients and will be marketed and distributed by Digital Angel's sister company, VeriChip, as an extension to the company's products benefiting people.
"A glucose-sensing microchip could profoundly impact the 230 million people worldwide living with diabetes," said Digital Angel CEO and President, Kevin McGrath. "Patent approval for this RFID microchip is a major step in bringing this life-altering technology to market. It also underscores Digital Angel's commitment to innovation, product development and rapid growth."
Checking blood glucose levels regularly is critical to properly managing diabetes. The conventional method - a finger prick - is invasive, painful and often inaccurate. The implantable bio-sensor chip has a passive transponder, glucose sensor and integrated circuitry that allow anyone implanted with the microchip to painlessly scan it to determine their level of glucose concentration. The RFID microchip quickly and accurately transmits the glucose data back to a wireless scanner that displays the glucose level. The RFID microchip is powered by the scanner signal, avoiding the need for a battery in the microchip.
"This is a landmark development in the world of diabetes management," said Dr. Joseph Feldman, Chairman of the Emergency/Trauma Department of Hackensack University Medical Center. "The current process for monitoring blood sugar levels is painful, cumbersome and discouraging, and especially burdensome for the young and the elderly. By having this technology, the process becomes effortless. This glucose-sensing RFID microchip is the next great step in implantable microchip technology."
Digital Angel, a leading producer of electronic tags for livestock, pets, fish and humans, foresees expansion beyond the human market for the glucose-sensing RFID microchip. According to the company, diabetes is a major disease issue in animal livestock today. As a result, the glucose-sensing RFID microchip could have an equally significant impact in monitoring the glucose levels in livestock animals.
"We recognize that extensive work is required to commercialize this product, including the time and investment required for development, clinical trials and FDA approval," said McGrath. "Still, we view this as an incredibly important advancement in the world of diabetes management."
Digital Angel is seeking international patent protection covering the same glucose-sensor RFID technology. The company, in conjunction with VeriChip Corporation, its exclusive licensee in the area of human implantable identification products, is in the process of naming this product.
The patent, No. 7,125,382 was granted on October 24, 2006 and is titled "Embedded Bio-Sensor System."
About Digital Angel Corporation
Digital Angel Corporation develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (ADSX). For more information about Digital Angel, please visit www.DigitalAngelCorp.com.
The statements in this press release that are not strictly historical, are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to be covered by the safe harbors created by these sections. The forward-looking statements are subject to risks and uncertainties and the actual results that the Company achieves may differ materially from these forward-looking statements due to such risks and uncertainties, including, but not limited to, that Applied Digital Inc. owns 55.4% of the Company's common stock, that new accounting pronouncements regarding expensing of share based compensation may impact the Company's future results of operations, the Company may continue to incur net losses, infringement by third parties on the Company's intellectual property or development of substantially equivalent proprietary technology by the Company's competitors could negatively impact the Company's business, domestic and foreign government regulation and other factors could impair the Company's ability to develop and sell its products in certain markets, the Company relies on sales to government contractors for its animal identification and search and rescue beacon products, and any decline in the demand by these customers for such products could negatively affect the Company's business, the Company depends on a single production arrangement for its patented syringe-injectable microchips, and the loss of or any significant reduction in the production could have an adverse effect on the Company's business, technological change could cause the Company's products to become obsolete, the loss of one of the Company's principal customers could negatively impact the Company's net revenue, the Company's earnings will decline if the Company writes off goodwill and other intangible assets, options and warrants outstanding and available for issuance may adversely affect the market price of the Company's common stock, currency exchange rate fluctuations could have an adverse effect on the Company's sales and financial results, the Company depends on a small team of senior management. A detailed statement of risks and uncertainties is contained in the Company's reports to the Securities and Exchange Commission, including in particular the Company's Form 10-K for the fiscal year ended December 31, 2005. Investors and stockholders are urged to read this document carefully. The Company can offer no assurances that any projections, assumptions or forecasts made or discussed in this release will be met, and investors should understand the risks of investing solely due to such projections. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
SOURCE: Digital Angel Corporation
Getting some respect...
Nice pop...
formula typo...
prediction formula reads, "...2314 (W1 = .618W1 + W3)... should read, "...2314 (W5 = .618W1 + W3)...
So far an 8 point over shoot from 2012 w/in the margin of error (and WELL w/in my margin of error...)
A
Comp guesstimate suggests that this might be about it for the move up. May see a correction of the whole move from July. Tighter stops can't hurt.
A
PS...for safety's sake, NEVER fade Cash's or Aires analysis no matter what anyone else predicts...
Posted by: Ayock
In reply to: None Date:10/5/2006 12:17:43 PM
Post #of 23384
My 2 cents on the comp (via Ewave)...
After a W4 (.238 = 2203 actual) retracement, W5 running full length predicts 2309 (W1=W5) or 2314 (W1 = .618W1 + W3) to end this move up.
So that pesky Ewave analysis suggests we start correcting this entire impulsive move from the July 18 (2012) low very soon.
Correction predicts 2197 as a standard move down on a larger degree W2.
Other bounce turn candidates (ie: tighten stops if you go short) are
.236 = 2240
.382 = 2197 (standard)
.618 = 2126
However...
If the comp blasts thru 2309 look for 2376 (1.618 = math for an extended Wave 5 move)as the next major turn resistance.
All the above for entertainment purposes only...
A
Comp guesstimate suggests that this might be about it for the move up. May see a correction of the whole move from July. Tighter stops can't hurt.
A
PS...for safety's sake, NEVER fade Cash's or Aires analysis no matter what anyone else predicts...
Posted by: Ayock
In reply to: None Date:10/5/2006 12:17:43 PM
Post #of 23384
My 2 cents on the comp (via Ewave)...
After a W4 (.238 = 2203 actual) retracement, W5 running full length predicts 2309 (W1=W5) or 2314 (W1 = .618W1 + W3) to end this move up.
So that pesky Ewave analysis suggests we start correcting this entire impulsive move from the July 18 (2012) low very soon.
Correction predicts 2197 as a standard move down on a larger degree W2.
Other bounce turn candidates (ie: tighten stops if you go short) are
.236 = 2240
.382 = 2197 (standard)
.618 = 2126
However...
If the comp blasts thru 2309 look for 2376 (1.618 = math for an extended Wave 5 move)as the next major turn resistance.
All the above for entertainment purposes only...
A
My 2 cents on the comp (via Ewave)...
After a W4 (.238 = 2203 actual) retracement, W5 running full length predicts 2309 (W1=W5) or 2314 (W1 = .618W1 + W3) to end this move up.
So that pesky Ewave analysis suggests we start correcting this entire impulsive move from the July 18 (2012) low very soon.
Correction predicts 2197 as a standard move down on a larger degree W2.
Other bounce turn candidates (ie: tighten stops if you go short) are
.236 = 2240
.382 = 2197 (standard)
.618 = 2126
However...
If the comp blasts thru 2309 look for 2376 (1.618 = math for an extended Wave 5 move)as the next major turn resistance.
All the above for entertainment purposes only...
A
Posted by: Ayock
In reply to: None
Date:9/19/2006 3:03:23 PM
Post #of 23304
ewave math update/recompute
recomputing turn points to watch from the Fri/Mon 2247 high suggests the following for bouce.
W4 retracement predictions from 2247:
.236 = 2200.40 (Low so far today = 2202.92 + bouncing off 50dma)
.382 = 2171
.5 = 2147
.618 = 2124
Digital Angel Targets $100 Million Equine Market; California Has Ordered 4,000 Bio-Thermo Chips for Horses; 500 Chips Already Implanted; Company Plans to Launch National Marketing Effort
By BusinessWire
Last Update: 9/25/2006 8:30:24 AM Data provided by
SO. ST. PAUL, Minn., Sep 25, 2006 (BUSINESS WIRE) -- Following strong demand for its Bio-Thermo(TM) chip in California and a successful regional marketing program, Digital Angel Corporation (DOC) today announced an aggressive national initiative to target the more than $100 million equine market for identification products with its patented, temperature-sensing implantable microchip.
The product, Bio-Thermo(TM), will provide approximately 8 million horses in the United States with a unique identification and health status surveillance required by local and state equine animal health professionals. Digital Angel, which specializes in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets, is in discussions with several large distributors.
"This is a major development for Digital Angel. The early results of our current program in Southern California have been overwhelmingly positive. Since late last year the California Horseracing Board, a division of the California Department of Agriculture, has been using federal funds to implant all new, in-coming young horses entering their racing career, with the Digital Angel Bio-Thermo chips," said President and CEO Kevin N. McGrath. "To date, the California Horseracing Board has purchased 1,500 Bio-Thermo chips, out of an order of 4,000, and an estimated 500 horses at Southern California racetracks have already been successfully implanted."
According to the company, The New York State Horse Health Assurance Program recently implemented a comprehensive health campaign that utilizes Bio-Thermo chips, and other state agencies are expected to launch similar programs.
The bio-thermo microchip is about the size of a grain of rice. It is easily, and harmlessly, injected into the crest of a horse's neck. The chip monitors the horse's temperature, which is a good indicator of the animal's health. The chip also contains a unique identification number that, when activated by a scanner, can be connected to a database with the horse's documentation.
Digital Angel has made significant progress in its electronic tags for livestock segment, a critical growth area for the company. It expects to post record-breaking numbers by the end of September, anticipating sales of 1.9 million electronic RFID livestock in the first nine months of 2006, rapidly exceeding full-year 2005 sales. Additionally, the U.S. Department of Agriculture named Digital Angel the first animal tag manufacturer in the government-sponsored National Animal Identification System program, underscoring the company's leadership position in the market.
"In bringing this new heat-sensing technology to the robust equine market, we are building from our leadership position in implantable tracking devices for livestock, pets and fish," said McGrath. "We are confident that nearly every horse in the United States can benefit from our Bio-thermo microchips, which will provide proper documentation, monitoring for infectious diseases, and preventing theft."
The announcement of the national equine chipping program reinforces the company's commitment to expand revenues and drive shareholder and market value. Digital Angel is already marketing the Bio-Thermo chip in the companion pet markets in the United Kingdom and Japan.
About Digital Angel Corporation
Digital Angel Corporation (www.DigitalAngelCorp.com) develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (ADSX).
The statements in this press release that are not strictly historical, are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to be covered by the safe harbors created by these sections. The forward-looking statements are subject to risks and uncertainties and the actual results that the Company achieves may differ materially from these forward-looking statements due to such risks and uncertainties, including, but not limited to, that Applied Digital Inc. owns 55.4% of the Company's common stock, that new accounting pronouncements regarding expensing of share based compensation may impact the Company's future results of operations, the Company may continue to incur net losses, infringement by third parties on the Company's intellectual property or development of substantially equivalent proprietary technology by the Company's competitors could negatively impact the Company's business, domestic and foreign government regulation and other factors could impair the Company's ability to develop and sell its products in certain markets, the Company relies on sales to government contractors for its animal identification and search and rescue beacon products, and any decline in the demand by these customers for such products could negatively affect the Company's business, the Company depends on a single production arrangement for its patented syringe-injectable microchips, and the loss of or any significant reduction in the production could have an adverse effect on the Company's business, technological change could cause the Company's products to become obsolete, the loss of one of the Company's principal customers could negatively impact the Company's net revenue, the Company's earnings will decline if the Company writes off goodwill and other intangible assets, options and warrants outstanding and available for issuance may adversely affect the market price of the Company's common stock, currency exchange rate fluctuations could have an adverse effect on the Company's sales and financial results, the Company depends on a small team of senior management. A detailed statement of risks and uncertainties is contained in the Company's reports to the Securities and Exchange Commission, including in particular the Company's Form 10-K for the fiscal year ended December 31, 2005. Investors and stockholders are urged to read this document carefully. The Company can offer no assurances that any projections, assumptions or forecasts made or discussed in this release will be met, and investors should understand the risks of investing solely due to such projections. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
SOURCE: Digital Angel Corporation
ADSX = the real deal
Digital Angel Targets $100 Million Equine Market; California Has Ordered 4,000 Bio-Thermo Chips for Horses; 500 Chips Already Implanted; Company Plans to Launch National Marketing Effort
By BusinessWire
Last Update: 9/25/2006 8:30:24 AM Data provided by
SO. ST. PAUL, Minn., Sep 25, 2006 (BUSINESS WIRE) -- Following strong demand for its Bio-Thermo(TM) chip in California and a successful regional marketing program, Digital Angel Corporation (DOC) today announced an aggressive national initiative to target the more than $100 million equine market for identification products with its patented, temperature-sensing implantable microchip.
The product, Bio-Thermo(TM), will provide approximately 8 million horses in the United States with a unique identification and health status surveillance required by local and state equine animal health professionals. Digital Angel, which specializes in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets, is in discussions with several large distributors.
"This is a major development for Digital Angel. The early results of our current program in Southern California have been overwhelmingly positive. Since late last year the California Horseracing Board, a division of the California Department of Agriculture, has been using federal funds to implant all new, in-coming young horses entering their racing career, with the Digital Angel Bio-Thermo chips," said President and CEO Kevin N. McGrath. "To date, the California Horseracing Board has purchased 1,500 Bio-Thermo chips, out of an order of 4,000, and an estimated 500 horses at Southern California racetracks have already been successfully implanted."
According to the company, The New York State Horse Health Assurance Program recently implemented a comprehensive health campaign that utilizes Bio-Thermo chips, and other state agencies are expected to launch similar programs.
The bio-thermo microchip is about the size of a grain of rice. It is easily, and harmlessly, injected into the crest of a horse's neck. The chip monitors the horse's temperature, which is a good indicator of the animal's health. The chip also contains a unique identification number that, when activated by a scanner, can be connected to a database with the horse's documentation.
Digital Angel has made significant progress in its electronic tags for livestock segment, a critical growth area for the company. It expects to post record-breaking numbers by the end of September, anticipating sales of 1.9 million electronic RFID livestock in the first nine months of 2006, rapidly exceeding full-year 2005 sales. Additionally, the U.S. Department of Agriculture named Digital Angel the first animal tag manufacturer in the government-sponsored National Animal Identification System program, underscoring the company's leadership position in the market.
"In bringing this new heat-sensing technology to the robust equine market, we are building from our leadership position in implantable tracking devices for livestock, pets and fish," said McGrath. "We are confident that nearly every horse in the United States can benefit from our Bio-thermo microchips, which will provide proper documentation, monitoring for infectious diseases, and preventing theft."
The announcement of the national equine chipping program reinforces the company's commitment to expand revenues and drive shareholder and market value. Digital Angel is already marketing the Bio-Thermo chip in the companion pet markets in the United Kingdom and Japan.
About Digital Angel Corporation
Digital Angel Corporation (www.DigitalAngelCorp.com) develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (ADSX).
The statements in this press release that are not strictly historical, are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to be covered by the safe harbors created by these sections. The forward-looking statements are subject to risks and uncertainties and the actual results that the Company achieves may differ materially from these forward-looking statements due to such risks and uncertainties, including, but not limited to, that Applied Digital Inc. owns 55.4% of the Company's common stock, that new accounting pronouncements regarding expensing of share based compensation may impact the Company's future results of operations, the Company may continue to incur net losses, infringement by third parties on the Company's intellectual property or development of substantially equivalent proprietary technology by the Company's competitors could negatively impact the Company's business, domestic and foreign government regulation and other factors could impair the Company's ability to develop and sell its products in certain markets, the Company relies on sales to government contractors for its animal identification and search and rescue beacon products, and any decline in the demand by these customers for such products could negatively affect the Company's business, the Company depends on a single production arrangement for its patented syringe-injectable microchips, and the loss of or any significant reduction in the production could have an adverse effect on the Company's business, technological change could cause the Company's products to become obsolete, the loss of one of the Company's principal customers could negatively impact the Company's net revenue, the Company's earnings will decline if the Company writes off goodwill and other intangible assets, options and warrants outstanding and available for issuance may adversely affect the market price of the Company's common stock, currency exchange rate fluctuations could have an adverse effect on the Company's sales and financial results, the Company depends on a small team of senior management. A detailed statement of risks and uncertainties is contained in the Company's reports to the Securities and Exchange Commission, including in particular the Company's Form 10-K for the fiscal year ended December 31, 2005. Investors and stockholders are urged to read this document carefully. The Company can offer no assurances that any projections, assumptions or forecasts made or discussed in this release will be met, and investors should understand the risks of investing solely due to such projections. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
SOURCE: Digital Angel Corporation
ewave math update/recompute
recomputing turn points to watch from the Fri/Mon 2247 high suggests the following for bouce.
W4 retracement predictions from 2247:
.236 = 2200.40 (Low so far today = 2202.92 + bouncing off 50dma)
.382 = 2171
.5 = 2147
.618 = 2124
Posted by: Ayock
In reply to: None Date:9/14/2006 3:06:32 PM
Post #of 23019
E-WAVE thoughts - COMP
My math count puts the comp as of today at the fibs end of a "3" from the 7/18 low. The distances traveled and retracements are almost perfectly standard, so the count is very clean. Looks something like this:
W1: 7/18 - 8/04
2012-2119 (actual distance)
W2: 8/04 - 8/10
2119 - 2048 (.618 retrace overshot by 4pts - 2052 predicted)
W3: 8/10 - 9/14
2048 - 2228 (1.618 = 2221 predicted so overshot by 7 pts so far)
this count predicts the following W4 retracement turns...
W4 retracement turn points to watch: 2185(.236)/2159(.382)/2138(.5)/2116(.618)
The W4 retracement favors the .382 level of 2159ish because that is very near the distance travelled of the previous w4 to the lesser degree (ie, w/in this 3 of 3)
All the above for entertainment purposes only and my be just BS.
A
comp...just a garden variety black candle /e
COMP
Looks to me like an island reversal is brewing. Tho with 200dma as support might be short lived...
E-WAVE thoughts - COMP
My math count puts the comp as of today at the fibs end of a "3" from the 7/18 low. The distances traveled and retracements are almost perfectly standard, so the count is very clean. Looks something like this:
W1: 7/18 - 8/04
2012-2119 (actual distance)
W2: 8/04 - 8/10
2119 - 2048 (.618 retrace overshot by 4pts - 2052 predicted)
W3: 8/10 - 9/14
2048 - 2228 (1.618 = 2221 predicted so overshot by 7 pts so far)
this count predicts the following W4 retracement turns...
W4 retracement turn points to watch: 2185(.236)/2159(.382)/2138(.5)/2116(.618)
The W4 retracement favors the .382 level of 2159ish because that is very near the distance travelled of the previous w4 to the lesser degree (ie, w/in this 3 of 3)
All the above for entertainment purposes only and my be just BS.
A
and also this as another revenue source...
VeriChip Corporation's VeriMed Patient Identification System Now Has 140 Hospitals and Approximately 300 Physicians as Part of Its Network
By BusinessWire
Last Update: 9/6/2006 8:00:59 AM Data provided by
DELRAY BEACH, Fla., Sep 06, 2006 (BUSINESS WIRE) -- VeriChip Corporation: VeriChip Trains Nearly 400 FEMA Employees on Its VeriTrace Emergency Management/Disaster Recovery Application
VeriChip Corporation, a subsidiary of Applied Digital Solutions (ADSX), announced today that its Implantable Division, consisting of the patient ID and personal health information system called "VeriMed", the security application called "VeriGuard", and the emergency management system called "VeriTrace" achieved important milestones. VeriMed, the first and only FDA-approved microchip for patient identification and access to medical information has advanced adoption in key areas of hospital and physician acceptance.
Since early August, 26 new healthcare facilities have agreed to adopt the VeriMed system. This brings the total to approximately 140 emergency departments, of which 36 - located in seven states and Washington, D.C. - have fully implemented the technology and will use the VeriMed reader as standard protocol to scan patients that present unconscious, delirious or confused. The Company continues to provide readers to hospitals at no charge as part of its efforts to "seed" the infrastructure for the VeriMed patient identification system.
The expansion of the VeriMed physician network has increased nearly six-fold in 2006, indicating increasing acceptance of VeriMed by primary care and specialty physicians.
"We are optimistic that we will see a significant increase in the number of physicians in our physician network as we enhance our efforts to educate physicians about the benefits of VeriMed through participation in several large medical conferences scheduled over the next few months," stated Kevin McLaughlin, CEO of VeriChip Corporation. "We are further encouraged that our clinical study program with Blue Cross Blue Shield of New Jersey, which commences in September, will lead to increased adoption by physicians and health insurers."
VeriChip's VeriTrace application is designed to assist state and federal agencies to plan for and manage emergency situations and disaster recovery using implantable RFID technology. VeriChip has now trained nearly 400 FEMA employees on this technology including the Disaster Mortuary Operational Response Teams (DMORT) involved in the recovery efforts during the aftermath of Hurricane Katrina and responsible for Weapons of Mass Destruction recovery efforts. VeriChip continues to work with federal and state agencies on full implementation of this technology.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.
About Applied Digital - "The Power of Identification Technology"
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (AMEX:DOC - News).
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
SOURCE: VeriChip Corporation
Zork
"...from $1.50..."...yup, me too.
Watch to see if there is any spark around the 18th based on this investor conference. Digital Angel is a majority owned subsidiary of ADSX.
Digital Angel to Present at the Third Annual Merriman Curhan & Ford Co. Investor Summit in San Francisco
By PR Newswire
Last Update: 9/12/2006 7:36:08 AM Data provided by
SO. ST. PAUL, Minn., Sept 12, 2006 /PRNewswire-FirstCall via COMTEX/ -- Digital Angel Corporation (DOC) an advanced technology company in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets today announced that it will be presenting to institutional investors at Merriman Curhan Ford & Co.'s Investor Summit 2006 on September 18th in San Francisco.
Kevin McGrath, President & CEO of Digital Angel is scheduled to speak at 10:45 a.m. PDT in the George D. Smith room on the Mezzanine Level of the Mark Hopkins InterContinental Hotel located at 1 Nob Hill Circle and will also be available for meetings with institutional investors. For more information on the conference go to www.merrimanco.com
About Digital Angel Corporation
Digital Angel Corporation develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of pets, fish, livestock, poultry and humans through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors. Digital Angel Corporation is a majority-owned subsidiary of Applied Digital (ADSX).
For more information about Digital Angel, visit the company's website at www.DigitalAngelCorp.com.
SOURCE Digital Angel Corporation
ADSX chart
ADSX getting ready to blow...
$1.73 should begin the breakout
A
Ever hear of these guys?
SqueezeTrigger.com is a new one on me...but could be an interesting site for DD.
disclosure...long ADSX - flat
BUYINS.NET: ADSX Are Crossing Above Their [bold}SqueezeTrigger.com[/bold] Prices Right Now.
By M2
Last Update: 9/13/2006 10:06:26 AM Data provided by
Sep 13, 2006 (M2 PRESSWIRE via COMTEX) -- www.squeezetrigger.com is monitoring APPLIED DIGITAL S (ADSX) in real time and just received alerts that each of these stocks are crossing above one of their key SqueezeTrigger Prices, the price that a short squeeze can start in each stock.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com APPLIED DIGITAL S (ADSX) has had 134948 shares shorted at a volume weighted average short price of $1.670. $224,283.00 was shorted at this level and may begin short squeezing imminently. This represents a portion of the total short volume since January 2005. To see all the data, please visit SqueezeTrigger.com . As of August 10th, the Total Short Interest was 2828452 shares. There are $4,723,514.84 worth of shares that have been shorted and have not yet covered. Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly one billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
CONTACT: Thomas Ronk, CEO, www.SqueezeTrigger.com Tel: +1 800 715 9999 e-mail: Tom@SqueezeTrigger.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
ADSX reversal candle setting up
over sold w/++ money flow
A